From 23 June, some people living with obesity may be eligible to access tirzepatide (Mounjaro®) for weight loss purposes in a primary care setting as outlined in NICE guidelines. Treatment arrangements are still being finalised in Gloucestershire for this service. In the meantime, please do not make an appointment to discuss this with the GP. We will keep this page updated with the arrangements when we are able. Please see the following link for information: https://www.nhsglos.nhs.uk/your-health-services/healthy-communities/weight-loss-medication/